Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerolama Condorelli

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2025
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulationGiada De Luca, Gianluca Petrillo, Iolanda Scognamiglio, et al.
Journal of the American Heart Association|February 4, 2022
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk PatientsCarlo A Pivato, Bernhard Reimers, Luca Testa, et al.
Journal of Medicinal Chemistry|October 20, 2021
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 InhibitorsPasquale Russomanno, Giulia Assoni, Jussara Amato, et al.
Cell Death Discovery|March 12, 2025
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1Cristina Quintavalle, Francesco Ingenito, Giuseppina Roscigno, et al.
Blood Advances|July 2, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphomaClaudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli, et al.
BMC Medical Genetics|January 25, 2013
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetesNatalia V Rivera, Robert Carreras-Torres, Roberta Roncarati, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2022
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 AptamersVladimir Mironov, Irina A Shchugoreva, Polina V Artyushenko, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Nature Medicine|December 14, 2011
EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancersMichela Garofalo, Giulia Romano, Gianpiero Di Leva, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2025
Fibroblasts activated by miRs-185-5p, miR-652-5p, and miR-1246 shape the tumor microenvironment in triple-negative breast cancer via PATZ1 downregulationGiada De Luca, Gianluca Petrillo, Iolanda Scognamiglio, et al.
Journal of the American Heart Association|February 4, 2022
One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk PatientsCarlo A Pivato, Bernhard Reimers, Luca Testa, et al.
Journal of Medicinal Chemistry|October 20, 2021
Interfering with the Tumor-Immune Interface: Making Way for Triazine-Based Small Molecules as Novel PD-L1 InhibitorsPasquale Russomanno, Giulia Assoni, Jussara Amato, et al.
Cell Death Discovery|March 12, 2025
Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1Cristina Quintavalle, Francesco Ingenito, Giuseppina Roscigno, et al.
Blood Advances|July 2, 2025
BH3 mimetic drugs overcome the microenvironment-induced resistance to crizotinib in ALK+ anaplastic large cell lymphomaClaudia Pignataro, Pietro Zoppoli, Luca Vincenzo Cappelli, et al.
BMC Medical Genetics|January 25, 2013
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetesNatalia V Rivera, Robert Carreras-Torres, Roberta Roncarati, et al.
Neuro-Oncology|August 30, 2025
Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy ConsortiumChetan Bettegowda, Houtan Noushmehr, Alessandra Affinito, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|January 13, 2022
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 AptamersVladimir Mironov, Irina A Shchugoreva, Polina V Artyushenko, et al.
Pageof 10